HHS’ Office for Civil Rights (OCR) amended previously-issued guidance asserting that the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule permits covered entities to contact individuals who have recovered from COVID-19 to inform them about how they can donate their plasma containing antibodies (known as “convalescent plasma”) to help treat others with COVID-19. Originally directed specifically to healthcare providers, OCR extended the guidance to include health plans. This guidance follows President Trump’s recent remarks encouraging commercial labs, insurers, providers, and pharmacies to send communications to individuals who have recovered from COVID-19 encouraging them to donate their convalescent plasma as well as the FDA’s recent issuance of an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in some hospitalized patients.